Calendar  Volatility Report 7/7/2008  Volatility Report 7/8/2008  Volatility Report 7/9/2008  
Martek Biosciences Corporation (MATK) is at an implied volatility extreme low of 34.94% that is less than 97.32% of past values prior to 7/8/2008 (Close Price 34.67). On prior close, 7/7/2008, the implied volatility was 44.13% and at the 46.14 percentile. Closing price was 33.16.

Today's News on Martek Biosciences Corporation

Six Ways to Profit from the Mini-Baby Boom (at Seeking Alpha)

Martek's life'sDHA & life'sARA(TM) Now Available in Wimm-Bill-Dann Infant Formula Products in Russia (PR Newswire)
Nasdaq: MATK - News) - Martek Biosciences Corporation announced today that its DHA and ARA blend, life'sDHA & life'sARA, is now available in Wimm-Bill-Dann infant formula products in Russia.

/C O R R E C T I O N -- Martek Biosciences Corporation/ (PR Newswire)
News) over PR Newswire, we are advised by the company that the headline should read "Third Quarter" rather than "Second" as originally issued inadvertently.

Baby 'Boomlet' Gives Birth to New Opportunities (CNBC)
The pitter-patter of little feet and the high-pitched cries of infants may seem louder lately, but it's music to the ears of many companies that cater to infants and children.

Baby stocks may grow up fast for Bespoke-Barron's (at Reuters)

A service of Trotter Trading Systems
Friday, Aug 29, 2008